Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Revest

Showing results (21-30 of 103) with videos related to

Pageof 11
Sort By:
Vaccine|September 23, 2008
Comparison of the immunomodulatory effects of L. donovani and L. major excreted-secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cellsMatthieu Revest, Ludovic Donaghy, Florian Cabillic, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2023
Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo modelSébastien Lalanne, Vincent Cattoir, François Guerin, et al.
Comparative Immunology, Microbiology and Infectious Diseases|January 31, 2012
Q fever osteomyelitis: a case report and literature reviewVicky Merhej, Pierre Tattevin, Matthieu Revest, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 8, 2011
Detection of HHV-6 in over a thousand samples: new types of infection revealed by an analysis of positive resultsMatthieu Revest, Sophie Minjolle, David Veyer, et al.
International Journal of Antimicrobial Agents|May 14, 2013
Clostridium difficile infections: do we know the real dimensions of the problem?Pierre Tattevin, Sylvie Buffet-Bataillon, Pierre-Yves Donnio, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2024
Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipientDavid Luque-Paz, Sébastien Lalanne, Juliette Besombes, et al.
The Lancet. Global Health|April 12, 2017
Socioenvironmental factors of communicable and non-communicable diseasesCatherine Cavalin, Alain Lescoat, Odile Macchi, et al.
Clinical Chemistry and Laboratory Medicine|October 22, 2010
Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical applicationMarie-Clémence Verdier, Danièle Bentué-Ferrer, Olivier Tribut, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Increased risk of renal stones in patients treated with atazanavirPierre Tattevin, Matthieu Revest, Jean-Marc Chapplain, et al.
Leukemia & Lymphoma|August 29, 2012
Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemiaTony Marchand, Matthieu Revest, Pierre Tattevin, et al.
Pageof 11

Showing results (21-30 of 103) with videos related to

Sort By:
Pageof 11
Vaccine|September 23, 2008
Comparison of the immunomodulatory effects of L. donovani and L. major excreted-secreted antigens, particulate and soluble extracts and viable parasites on human dendritic cellsMatthieu Revest, Ludovic Donaghy, Florian Cabillic, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2023
Differential response to antibiotic therapy in staphylococcal infective endocarditis: contribution of an ex vivo modelSébastien Lalanne, Vincent Cattoir, François Guerin, et al.
Comparative Immunology, Microbiology and Infectious Diseases|January 31, 2012
Q fever osteomyelitis: a case report and literature reviewVicky Merhej, Pierre Tattevin, Matthieu Revest, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 8, 2011
Detection of HHV-6 in over a thousand samples: new types of infection revealed by an analysis of positive resultsMatthieu Revest, Sophie Minjolle, David Veyer, et al.
International Journal of Antimicrobial Agents|May 14, 2013
Clostridium difficile infections: do we know the real dimensions of the problem?Pierre Tattevin, Sylvie Buffet-Bataillon, Pierre-Yves Donnio, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 2024
Absence of maribavir penetration into the central nervous system: confirmation by multiple cerebrospinal fluid dosages in a solid organ transplant recipientDavid Luque-Paz, Sébastien Lalanne, Juliette Besombes, et al.
The Lancet. Global Health|April 12, 2017
Socioenvironmental factors of communicable and non-communicable diseasesCatherine Cavalin, Alain Lescoat, Odile Macchi, et al.
Clinical Chemistry and Laboratory Medicine|October 22, 2010
Determination of daptomycin in human plasma by liquid chromatography-tandem mass spectrometry. Clinical applicationMarie-Clémence Verdier, Danièle Bentué-Ferrer, Olivier Tribut, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 10, 2013
Increased risk of renal stones in patients treated with atazanavirPierre Tattevin, Matthieu Revest, Jean-Marc Chapplain, et al.
Leukemia & Lymphoma|August 29, 2012
Early cryptococcal meningitis following treatment with rituximab, fludarabine and cyclophosphamide in a patient with chronic lymphocytic leukemiaTony Marchand, Matthieu Revest, Pierre Tattevin, et al.
Pageof 11